drugset / Trial / NCT02393677
Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine
RandomizedParallel-groupDouble-blindSupportive care
Summary
80 American Society of Anesthesiologists (ASA) grade I-II patients, 18-60 years old,scheduled for elective upper limb orthopaedic surgery under supraclavicular brachial plexus block, were included in this prospective study. The patients were randomly assigned to group R (Ropivacaine alone) and group RD (Ropivacaine and dexmedetomidine) (40 patients in each group). Group R received Ropivacaine 0.50% (30 cc) + placebo and group RD received Ropivacaine 0.50% (30 cc) + dexmedetomidine 1 µg/kg.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 30 ml | Other |
Indications
No indication recorded.